Blog | Pharmaceuticals

Taking an integrated clinical and regulatory approach for the prebiotic/probiotic market

Posted by Jennifer Andrews, M.Sc. on Wed, Jan 27, 2016

Prebiotics and probiotics aren't going anywhere. In fact, this emerging market has become so popular in recent years that there are now two major events dedicated solely to prebiotics/probiotics.

Our clinical team will be attending Probiota Global (Amsterdam, Feb 2-4, 2016) and Probiota Americas (Chicago, May 31-June 2, 2016) to share knowledge, explore new opportunities and network within this exciting area of health research.

As we gear up for next week's conference, we take a look at one of the most challenging aspects of the research and development (R&D) process for companies looking to bring prebiotics/probiotics to market.

Read More

0 Comments Click here to read/write comments

Tags: Natural Health Products, Dietary Supplements, Clinical Research, Pharmaceuticals, Regulatory, Foods

Discover the optimal regulatory pathway for your omega-3 product at GOED Exchange 2016

Posted by Jennifer Andrews, M.Sc. on Tue, Jan 12, 2016

Omega-3s are one of the most studied and widely available natural products. Why aren't there more prescription omega-3s on the market?

Read More

0 Comments Click here to read/write comments

Tags: Dietary Supplements, Omega-3s, Pharmaceuticals, Regulatory

Laboratory Testing Feature: Isolation and Characterization of Trace Impurities in Pharmaceutical Products

Posted by Dr. Theo Kapanadze, D.Sc., Ph.D. on Fri, Jan 03, 2014

This month our laboratory testing feature, written by Dr. Theo Kapanadze, of Diteba (Nutrasource's analytical laboratory) focuses on the isolation and characterization of trace impurities in pharmaceutical products.

Read More

0 Comments Click here to read/write comments

Tags: Product Testing, Pharmaceuticals, Regulatory

Laboratory Feature: Perspectives on Guidelines for Dermal Absorption and Quality of Transdermal Patches

Posted by Dr. Theo Kapanadze, D.Sc., Ph.D. on Thu, Sep 26, 2013

Transdermal patches are designed to slowly deliver the drug substances through the intact skin, resulting in a prolonged and adequately constant systemic absorption rate. The rate limiting step for systemic absorption of the drug substance is usually the absorption through the skin. Absorption may also be limited by incorporating or dissolving the drug substance in a semisolid reservoir with a membrane to control the release and the diffusion of the drug substance(s) from the transdermal patch. A transdermal patch can also be formulated combining both drug delivery principles as the means of controlling drug delivery to the surface of the skin.

Read More

0 Comments Click here to read/write comments

Tags: Product Testing, Pharmaceuticals

Definition of ‘Drug’ Challenged in a Lawsuit Against Health Canada

Posted by Jennifer Andrews, M.Sc. on Thu, Dec 13, 2012

A lawsuit was filed against Health Canada on September 21, 2012, challenging the definition of “drug” under the Food and Drugs Act. The plaintiffs, which include an actor and naturopathic doctor, argue that dietary supplements are not drugs and should therefore not be regulated as drugs.

Read More

0 Comments Click here to read/write comments

Tags: Natural Health Products, Pharmaceuticals, Regulatory

All posts